Get the Stockscreener App
21.72
2.84%
0.60
Quantum Biopharma Ltd stock is traded at $21.72, with a volume of 297.32K.
It is up +2.84% in the last 24 hours and up +87.73% over the past month.
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
See More
Previous Close:
$21.12
Open:
$20.65
24h Volume:
297.32K
Relative Volume:
0.50
Market Cap:
$44.69M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-37.94%
1M Performance:
+87.73%
6M Performance:
+434.98%
1Y Performance:
+0.00%
1-Day Range:
$20.50
$24.32
1-Week Range:
$20.05
$32.58
52-Week Range:
$2.70
$38.25
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Compare QNTM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
21.72 | 44.69M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.83 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.14 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
241.20 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Quantum Biopharma Ltd Stock (QNTM) Latest News
Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress - Newsfile
Keg, LQWD, Quantum at 52-Week Highs on News - Baystreet.ca
Quantum BioPharma Ltd. Initiates Groundbreaking MS Study with Massachusetts General Hospital - citybuzz -
Quantum BioPharma Says First Person With Multiple Sclerosis Scanned in Joint Study With Hospital - MarketScreener
Quantum BioPharma and MGH Launch MS Study with Novel Imaging Technique - TipRanks
Quantum BioPharma (QNTM) Initiates MS Imaging Study with Massachusetts General | QNTM Stock News - GuruFocus
Quantum BioPharma Announces First Person with Multiple - GlobeNewswire
Revolutionary MS Brain Imaging Study Launches at Harvard's MGH: First Patient Milestone Achieved - Stock Titan
Quantum BioPharma Ltd. Announces Special Dividend Linked to Litigation Proceeds - citybuzz -
Quantum BioPharma (QNTM) Announces Special Dividend in CVRs | QN - GuruFocus
Quantum BioPharma boosts investments in digital assets to $5M - MSN
Quantum BioPharma plans special dividend tied to legal action By Investing.com - Investing.com South Africa
Quantum BioPharma plans special dividend tied to legal action - Investing.com
Quantum Biopharma Plans Special Dividend Linked to Potential Litigation Proceeds - marketscreener.com
Quantum BioPharma Announces Special Dividend Linked to Litigation Proceeds - TipRanks
Quantum BioPharma Ltd. Announces Special Dividend of Contingent Value Rights Linked to Ongoing Litigation Against Banks - Nasdaq
Quantum BioPharma Announces Intention to Declare Special - GlobeNewswire
Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds - GlobeNewswire Inc.
Quantum BioPharma Boosts Digital Asset Holdings To $5 Million With New Bitcoin Purchase - Bitcoin Magazine
Quantum Biopharma Purchases More Bitcoin Bringing Total Investment In Digital Assets To USD $5,000,000 - marketscreener.com
Quantum BioPharma (QNTM) Expands Cryptocurrency Holdings to $5 M - GuruFocus
Quantum BioPharma Expands Cryptocurrency Investment Portfolio - TipRanks
Quantum Biopharma Purchases More Bitcoin (BTC) Bringing the Total Investment in Digital Assets to USD $5,000,000 - GlobeNewswire
Quantum Biopharma Brief: Says Purchased More Bitcoin (BTC) Bringing Total Investment in Digital Assets to US$5 Million - marketscreener.com
Quantum Biopharma buys additional $1 million of Bitcoin, other cryptocurrencies - MSN
Quantum BioPharma clarifies misinformation on stock name, RTO rumors By Investing.com - Investing.com South Africa
Quantum BioPharma Ltd. Clarifies Misinformation Regarding Name Change and RTO Rumors - citybuzz -
Quantum BioPharma Clarifies Name Confusion, Refutes RTO Rumors With Unbuzzd Wellness - Nasdaq
Quantum BioPharma Clarifies It Has Not Changed Its Name | QNTM S - GuruFocus
Quantum BioPharma clarifies misinformation on stock name, RTO rumors - Investing.com
Quantum BioPharma clarifies company has not changed its name - TipRanks
Quantum BioPharma (QNTM) Clarifies Company Name and Transaction Rumors | QNTM Stock News - GuruFocus
Quantum BioPharma Addresses Misinformation and Financial Agreements - TipRanks
Quantum BioPharma Clarifies It Has Not Changed Its Name | QNTM Stock News - GuruFocus
Quantum BioPharma Addresses Misinformation Regarding Unbuzzd Wellness and Clarifies Stock Trading Platform Errors - Nasdaq
Quantum BioPharma Clarifies It Has Not Changed Its Name - GlobeNewswire
Quantum BioPharma Sets Record Straight: No Name Change, Reveals Major Unbuzzd Wellness Stake - Stock Titan
iNGENū CRO Partners with Quantum BioPharma to Launch - GlobeNewswire
Quantum BioPharma settles disputes with former CEO By Investing.com - Investing.com South Africa
Quantum BioPharma Resolves Legal Dispute with Former CEO, Secures $2.35 Million Settlement - citybuzz -
What's Going On With Quantum Biopharma Stock Today? - Benzinga
Quantum BioPharma (QNTM) Settles Disputes with Former CEO | QNTM Stock News - GuruFocus
Quantum BioPharma Settles Legal Dispute with Former CEO, Receives $2.35 Million - TipRanks
Quantum BioPharma settles disputes with former CEO - Investing.com
Quantum Biopharma Brief: Says Received US$2.35 Million From a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari - marketscreener.com
Quantum BioPharma Receives $2.35 Million USD from a - GlobeNewswire
Quantum BioPharma Ends 4-Year Legal Battle with $2.35M Settlement Payment from Ex-CEO - Stock Titan
Quantum BioPharma appoints MNP for IPO readiness audits By Investing.com - Investing.com South Africa
Unbuzzd Wellness Prepares for Potential IPO with New Auditor Appointment - citybuzz -
Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit - GuruFocus
Quantum BioPharma (QNTM) Engages New Auditor for Potential IPO | - GuruFocus
Quantum Biopharma Ltd Stock (QNTM) Financials Data
There is no financial data for Quantum Biopharma Ltd (QNTM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.11%
1.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):